COMMITMENT AND CONTINGENCES
|3 Months Ended|
Jan. 31, 2017
|Commitments and Contingencies Disclosure [Abstract]|
|Commitments and Contingencies Disclosure [Text Block]||
10. COMMITMENT AND CONTINGENCES
Patent Acquisition Obligations
As of January 31, 2017, we have incurred obligations due no later than November 2017 related to the acquisition of patents, which have a discounted present value of approximately $4,313,000, and which amount will be reduced by royalties paid during the period, if any. The payment due in November 2017 is payable at the option of the Company in cash or common stock. On January 27, 2017, the Company announced its intention to issue 947,606 shares of common stock in satisfaction of this obligation. We recorded interest expense of approximately $141,000 and $124,000, respectively, for the three months ended January 31, 2017 and 2016, for the accretion of interest on patent acquisition obligations.
Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.
The entire disclosure for commitments and contingencies.
Reference 1: http://www.xbrl.org/2003/role/presentationRef